February 24, 2018 3:25 PM ET

Life Sciences Tools and Services

Company Overview of Qu Biologics Inc.

Key Executives for Qu Biologics Inc.

NameBoard RelationshipsTitleAge
Hal Gunn M. D.16 RelationshipsCo-Founder and Chief Executive Officer--
Nicole Clendinning BA (Hons.), CPA, CGANo RelationshipsDirector of Finance--
Gillian Vandermeirsch Ph.D.No RelationshipsVice President of Operations--
Salim Dhanji Ph.D.No RelationshipsHead of Pre-Clinical Research--
Simon B. Sutcliffe M.D., FRCP, FRCPC, FRCR37 RelationshipsChief Medical Officer and Member of The Scientific Advisory Board70

Qu Biologics Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Simon B. Sutcliffe M.D., FRCP, FRCPC, FRCR 37 RelationshipsQu Biologics Inc.70
David G. Barnes M.D. 14 RelationshipsQu Biologics Inc.--
Kent R. Van Kampen D.V.M.,Ph.D. 11 RelationshipsQu Biologics Inc.--
Ralf Kleef M.D. 9 RelationshipsQu Biologics Inc.--
Brett A. Premack Ph.D. 9 RelationshipsSirona Biochem Corp.--
View All Board Members

Qu Biologics Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
337.2K
Bonus
143.6K
Total Short Term Compensation
377.6K
Total Value of Options
6.8M
Compensation as of Fiscal Year
Qu Biologics Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

ChromaDex Corporation Announces Resignation of Stephen Allen from Board of Directors
February 16, 2018 9:30 PM ET
Bio-Rad Laboratories, Inc. Announces the Resignation of John Goetz as Executive Vice President, Chief Operating Officer, Effective March 30, 2018
February 16, 2018 5:01 PM ET
CordenPharma Announces Executive Appointments
February 15, 2018 6:44 PM ET
Envigo International Holdings, Inc. Appoints Lynn Lewis as Senior Vice President of Global Sales
February 13, 2018 9:00 PM ET
AroCell AB (publ) Appoints Jon Eiken as Chairman of the Nomination Committee
February 13, 2018 6:32 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Qu Biologics Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.